Consistent with the promoter reporter assays, we also observed that the differential FAT10 expression in the tumors of HCC patients with haplotype I is slightly higher (7.14 ± 2.34) than the tumors of HCC patients with haplotype II (5.64 ± 3.06). Here, UBD is linked to hepatocellular carcinoma.